Can we talk about price with patients when choosing antiretroviral therapy? A survey with people living with HIV and prescribers in France.
Emmanuelle PapotNikos KalampalikisMarjolaine DoumergueFabrice PilorgéGuillemette QuatremèreYazdan YazdanpanahMarie Préaunull nullPublished in: BMJ open (2021)
A high proportion of PLWH gave a fair estimate of their ART price and this seemed unexpected by HIV specialists. Consideration of drug prices when choosing ART was perceived as conceivable by PLWH and prescribers if effectiveness and tolerance were also considered.
Keyphrases
- antiretroviral therapy
- hiv infected
- hiv positive
- human immunodeficiency virus
- hiv aids
- hiv infected patients
- end stage renal disease
- randomized controlled trial
- chronic kidney disease
- newly diagnosed
- ejection fraction
- prognostic factors
- depressive symptoms
- peritoneal dialysis
- physical activity
- hepatitis c virus
- emergency department
- hiv testing